Neuro-oncologist Na Tosha Gatson has launched a new column to simplify complex brain cancer concepts for doctors, patients, and caregivers.
The recurring feature, called The G.L.O.B., debuts this month as part of NeurologyLive’s Mind Moments podcast series. Gatson, who leads neuro-oncology at Indiana University School of Medicine, created the project after seeing critical information lost in medical jargon.
From frustration to a new platform
In a recent podcast interview, Gatson described her career as a blend of clinical work, research, and mentorship. She often struggled to explain difficult diagnoses in ways patients could understand. Families frequently left appointments confused, despite her efforts to simplify the science.
“You can spend an hour breaking down a treatment plan, only to realize the patient still doesn’t grasp the basics,” she said. “That disconnect can affect outcomes.”
The G.L.O.B. (short for Gatson’s Literacy Outreach in Brain Oncology) will translate dense oncologic research into practical insights. Early topics include interpreting MRI scans, managing immunotherapy side effects, and participating in clinical trials. Gatson wants the content to feel like a conversation rather than a textbook.
Health literacy in brain cancer care
Brain tumors are among the most difficult cancers to treat, with survival rates lagging behind other cancers. Gatson believes part of the problem stems from patients lacking the tools to advocate for themselves. A 2022 study in Neuro-Oncology found nearly 40% of brain cancer patients misunderstood their prognosis after consulting specialists.
“If patients don’t understand their diagnosis, they can’t make informed decisions about treatment,” she said. “Caregivers also need to grasp the basics to provide proper support at home.”
Related: Artists Merge Faith and Pop Culture
The column will address health equity, a key concern for Gatson. She highlighted disparities in access to clinical trials and advanced therapies, which affect Black and Hispanic patients more often. “Literacy means ensuring everyone, regardless of background, has the same chance to benefit from new treatments,” she explained.
Gatson’s method goes beyond simplifying language. She plans to use analogies, such as comparing tumor growth to weeds in a garden, and include interactive Q&A sections. The aim is to create a resource that feels more like a trusted guide than a medical lecture.
Brain tumors remain one of the deadliest cancers, with a five-year survival rate of 36% for malignant cases. Gatson hopes better communication might improve those numbers.
Success will depend on whether the column connects with its audience. A pilot survey of 200 neuro-oncology patients showed 78% wanted more resources to help them understand their condition. The challenge is providing clarity without oversimplifying the science.
The first installment arrives later this month, with new columns published quarterly. Gatson is already planning future topics, including how artificial intelligence is changing brain tumor diagnosis.
“This isn’t about reducing complexity,” she said. “It’s about ensuring the information reaches those who need it most.”